Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.20.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents $ 286,250 $ 6,208
Equity method investments 1,279,651 498,631
Net receivables 1,214,000  
Real estate 359,176 362,265
Investments 55,377 74,530
Securitization assets 164,342 123,979
Other assets 100,364 162,054
Total Assets 3,459,067 2,387,274
Liabilities:    
Accounts payable, accrued expenses and other 59,944 54,351
Credit facilities 22,591 31,199
Non-recourse debt (secured by assets of $723 million and $921 million, respectively) 592,547 700,225
Senior unsecured notes 1,283,335 512,153
Convertible notes 290,501 149,434
Total Liabilities 2,248,918 1,447,362
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 76,457,415 and 66,338,120 shares issued and outstanding, respectively 765 663
Additional paid in capital 1,394,009 1,102,303
Accumulated deficit (204,112) (169,786)
Accumulated other comprehensive income (loss) 12,634 3,300
Non-controlling interest 6,853 3,432
Total Stockholders’ Equity 1,210,149 939,912
Total Liabilities and Stockholders’ Equity 3,459,067 2,387,274
Government receivables    
Assets    
Receivables, net of allowance 248,455 263,175
Commercial receivables    
Assets    
Net receivables $ 965,452 $ 896,432